CAS number：1402796-27-3 molecular formula：C31H34F7NO3
CKD-519 is a selective and potent cholesteryl ester transfer protein (CETP) inhibitor, which inhibits CETP-mediated transfer of cholesteryl ester in human serum with an IC 50 of 2.3 nM Form:Solid IC50& Target:IC50: 2.3 nM (Cholesteryl ester transfer protein)
| Chinese alias | - | ||
| English alias | CKD-519 | DB15437 | Rocacetrapib [INN] | GBHPDJQHZADVAA-SOKVYYICSA-N | UNII-K9SP3L3YQP | 2-Oxazolidinone, 5-(3,5-bis(trifluoromethyl)phenyl)-3-((2-(4-fluoro-2-methoxy-5-(1-methylethyl)phenyl)-5,5-dimethyl-1-cyclohexen-1-yl)methyl)-4-methyl-, (4S,5R)- | 14 | ||
| CAS number | 1402796-27-3 | molecular formula | C31H34F7NO3 |
| molecular weight | 601.60 g/mol | Exact mass | ≥99% |
| PSA | 38.800 Ų | logp | 8.2 |
No numbering system information yet
No physical and chemical property information yet
No safety information yet
No production method and use information yet
No upstream information yet
No downstream information yet
